Target intelligence / Profile preview

CARNMT1 antisense RNA 1 (CARNMT1-AS1)

Target
CARNMT1-AS1
Molecular classification
Other (long noncoding RNA / antisense RNA gene)
01

Overview

CARNMT1 antisense RNA 1 (CARNMT1-AS1) is a long noncoding RNA (lncRNA) gene transcribed in antisense orientation relative to the CARNMT1 gene. While the protein-coding gene CARNMT1 encodes carnosine N-methyltransferase 1, a methyltransferase involved in histidine N1-methylation of dipeptides and certain RNA-binding proteins, the functions of CARNMT1-AS1 itself have not been well characterized in the public literature or major gene annotation resources. Such antisense RNAs commonly regulate their sense counterpart gene expression via various mechanisms, but specific functions, clinical significance, or disease relations of CARNMT1-AS1 remain currently undefined[4]. Key points supporting this assessment: - CARNMT1-AS1 is listed in gene databases as an RNA gene, not encoding a protein product, and there is no evidence of it being a therapeutic target (such as receptor, enzyme, transporter, etc.)[4]. - There are no listed drugs targeting CARNMT1-AS1, no mechanism of action for therapeutic agents, and it is not described as a biomarker or associated with specific diseases in current resources[4]. - These features differentiate it sharply from CARNMT1 protein, for which considerable biochemical and biological role detail is available, notably as a methyltransferase with roles in RNA and protein modification[1][2]. If you require information about the protein CARNMT1 (carnosine N-methyltransferase 1), please clarify, as it is a separate entity with direct biological and potential therapeutic significance[1][2].

02

Mechanism of action

Not applicable (no drugs or therapeutic targeting described)

03

Biological functions

Regulation of gene expression (potentially via antisense transcript mechanisms; detailed function not fully characterized)
04

Disease associations

Unknown (no established or direct evidence for specific involvement in disease as of current databases)

Beyond the preview

Go deeper on CARNMT1 antisense RNA 1 (CARNMT1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CARNMT1 antisense RNA 1 (CARNMT1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call